US Patent 9505745 Enhancer of zeste homolog 2 inhibitors

Patent 9505745 was granted and assigned to GlaxoSmithKline on November, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

GlaxoSmithKline

Current Assignee

GlaxoSmithKline

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9505745

Patent Inventor Names

Xinrong Tian0

Steven David Knight0

Stuart Paul Romeril0

William Henry Miller0

Charles William Blackledge, Jr.0

Dai-Shi Su0

Jiri Kasparec0

Joelle Lorraine Burgess0

...

Date of Patent

November 29, 2016

Patent Application Number

14787866

Date Filed

April 25, 2014

Patent Primary Examiner

‌

Zinna Northington Davis

Patent abstract

This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.